PAPER Zheng CB, Wu LZ, Song WY, Luo L, Cai JT, Huang ZH, Tian KQ
SEARCH RESULTS
347549 RESULTS
PAPER El Haj M, Gallouj K, Antoine P, Chapelet G
Prospective Memory in Mobile: Using Smartphone-Based Calendars to Rehabilitate Prospective Memory in Patients with Alzheimer's Disease.
Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.PAPER Li M, Wu X, Jiang L, Liu M, Yanju G, Li X, Tian F, Ye F, Wang J, Wang S, Qin C, Zhang L
Exploring the co-morbid relationship between Alzheimer's disease and lung cancer in the 5xFAD transgenic mouse model.
Animal Model Exp Med. 2025 Feb 10; Epub 2025 Feb 10 PubMed.PAPER Lamisa AB, Ahammad I, Bhattacharjee A, Hossain MU, Ishtiaque A, Chowdhury ZM, Das KC, Salimullah M, Keya CA
Publisher Correction: A meta-analysis of bulk RNA-seq datasets identifies potential biomarkers and repurposable therapeutics against Alzheimer's disease.
Sci Rep. 2025 Feb 11;15(1):5135. PubMed. Corrected paper.PAPER Meunier-Duperray L, Souchay C, Angel L, Salmon E, Bastin C
Exploring the domain specificity and the neural correlates of memory unawareness in Alzheimer's disease.
Neurobiol Aging. 2025 Apr;148:61-70. Epub 2025 Feb 5 PubMed.PAPER Yang L, Wang Y, Shang P, Ma G
Dual-Functional Synthetic Linear and Cyclic Peptides with Anti-Amyloid and Antimicrobial Activities for Alzheimer's Disease.
Chemistry. 2025 Mar 12;31(15):e202404349. Epub 2025 Feb 19 PubMed.PAPER Johnson JL
FKBP51 functions in regulation of circadian rhythm and Alzheimer's disease.
Cell Stress Chaperones. 2025 Feb 9; Epub 2025 Feb 9 PubMed.PAPER Jia F, Fu L
Roles of Ubiquitin Ligases and Deubiquitylases in Alzheimer's Disease.
Mol Neurobiol. 2025 Feb 11; Epub 2025 Feb 11 PubMed.PAPER Nuovo GJ, Rice M, Zanesi N, Sawant D, Crilly C, Tili E
The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2.
Appl Immunohistochem Mol Morphol. 2025 Feb 11; Epub 2025 Feb 11 PubMed.PAPER Arafi P, Devkota S, Williams E, Maesako M, Wolfe MS
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production.
Elife. 2025 Feb 11;13 PubMed.PAPER Stefani A, Antelmi E, Arnaldi D, Arnulf I, During E, Högl B, Hu MM, Iranzo A, Luke R, Peever J, Postuma RB, Videnovic A, Gan-Or Z
From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease.
Mol Neurodegener. 2025 Feb 11;20(1):19. PubMed.PAPER Furusawa-Nishii E, Solongo B, Rai K, Yoshikawa S, Chiba A, Okuzumi A, Ueno SI, Hoshino Y, Imamichi-Tatano Y, Kimura H, Hatano T, Hattori N, Miyake S
α-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson's disease.
J Neuroinflammation. 2025 Feb 11;22(1):38. PubMed.PAPER Otero-Jimenez M, Wojewska MJ, Binding LP, Jogaudaite S, Gray-Rodriguez S, Young AL, Gentleman S, Alegre-Abarrategui J
Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson's disease.
Acta Neuropathol Commun. 2025 Feb 11;13(1):25. PubMed.PAPER Simitsi AM, Sfikas E, Koros C, Papagiannakis N, Beratis I, Papadimitriou D, Antonellou R, Fragiadaki S, Kontaxopoulou D, Picillo M, Pachi I, Alefanti I, Stamelou M, Barone P, Stefanis L
Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study.
J Neurol. 2025 Feb 12;272(3):203. PubMed.PAPER Outeiro TF, Höglinger G, Lang AE, Vieira TC
Protein misfolding: understanding biology to classify and treat synucleinopathies.
J Neural Transm (Vienna). 2025 Feb 11; Epub 2025 Feb 11 PubMed.Current Filters
- Date Range : All x